Aristopharma Ltd. has launched Empaglif-M, a combination consisting of Empagliflozin INN & Metformin Hydrochloride BP as tablets
Empaglif-M is a combination of Empagliflozin and Metformin Hydrochloride indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both Empagliflozin and Metformin hydrochloride is appropriate.
Composition
Empaglif-M 5/500 Tablet: Each film-coated tablet contains Empagliflozin INN 5 mg & Metformin Hydrochloride BP 500 mg.
Empaglif-M 12.5/500 Tablet: Each film-coated tablet contains Empagliflozin INN 12.5 mg & Metformin Hydrochloride BP 500 mg.
Empaglif-M 10/1000 XR Tablet: Each film-coated tablet contains Empagliflozin INN 10 mg & Metformin Hydrochloride BP 1000 mg extended-release.
Empaglif-M 25/1000 XR Tablet: Each film-coated tablet contains Empagliflozin INN 25 mg & Metformin Hydrochloride BP 1000 mg extended-release.
FR
DE